CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831476348
- Phone
- (619) 728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-02 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −73,093 | $16.31 | $1.2M | 480,281 |
| 2024-02-02 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −2,300 | $17.04 | $39K | 477,981 |
| 2024-02-02 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,393 | 108,110 | ||
| 2024-02-02 | Harris Todd President and CEO | Sale 10b5-1 | −78,996 | $16.45 | $1.3M | 1,523,701 |
| 2024-02-02 | Harris Todd President and CEO | Sale 10b5-1 | −7,187 | $17.04 | $122K | 1,516,514 |
| 2023-09-15 | Tada Hiroomi Chief Medical Officer | Grant or award | +1,337 | $6.58 | $9K | 84,467 |
| 2023-09-15 | Harris Todd President and CEO | Grant or award | +1,421 | $6.58 | $9K | 1,602,697 |
| 2023-09-15 | Fuhrman Alan Chief Financial Officer | Grant or award | +1,463 | $12.50 | $18K | 1,463 |
| 2023-07-28 | Tada Hiroomi Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2023-07-28 | Harris Todd President and CEO | Grant or award · Stock Option (Right to Buy) | +330,000 | 330,000 |
Page 9 of 9 · 170 trades